Dr. Martens (LON:DOCS) Stock Price Down 12% – What’s Next?

Dr. Martens plc (LON:DOCS) shares traded down 12% on Tuesday . The company traded as low as GBX 64.60 and last traded at GBX 66.55. 2,111,753 shares were traded during mid-day trading, an increase of 27% from the average session volume of 1,659,168 shares. The stock had previously closed at GBX 75.65.

Wall Street Analyst Weigh In

DOCS has been the topic of a number of research analyst reports. Berenberg Bank reissued a “buy” rating on shares of Dr. Martens in a report on Tuesday. Peel Hunt reissued a “buy” rating on shares of Dr. Martens in a research note on Thursday, November 20th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 6,000.

Dr. Martens Price Performance

The firm has a fifty day moving average of GBX 75.88 and a two-hundred day moving average of GBX 83.26. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27. The company has a market capitalization of £660.64 million, a PE ratio of 40.21, a PEG ratio of 6.40 and a beta of 0.11.

Dr. Martens (LON:DOCS) last released its quarterly earnings data on Thursday, November 20th. The company reported GBX (0.90) earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. Research analysts anticipate that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Insider Activity

In other news, insider Robert Hanson bought 96,000 shares of the company’s stock in a transaction dated Friday, December 5th. The stock was bought at an average cost of GBX 79 per share, for a total transaction of £75,840. Insiders have bought a total of 97,130 shares of company stock valued at $7,673,816 in the last 90 days. 2.79% of the stock is currently owned by insiders.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.